Patients with compensated liver disease who remain high HBV-DNA levels after a 3—to 6 -month period of elevated ALT levels greater than 2 times of the upper limit of normal level (>50 U/L for women and >70 U/L for men) should be considered for antiviral treatment. The gene discussed is GPT; the disease is liver disorder.